USPTO serial 88693631
STEM
Reviewed by CopyMark Law Group
Status 654
- Filing date
- Status date
- Registration date
- —
- Examiner
- WOLFE, YOUNG J
- Law office
- TMO LAW OFFICE 122
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with STEM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Boca Raton, FL, US
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Ingredients for use in the manufacture of cosmetics, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; plant-based ingredients for use in the manufacture of cosmetics, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; botanical ingredients for use in the manufacture of cosmetics, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; herbal ingredients for use in the manufacture of cosmetics, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; agricultural ingredients for use in the manufacture of cosmetics, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; ingredients for use in the manufacture of pharmaceuticals, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; inactive ingredients for use in the manufacture of pharmaceuticals, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; ingredients for use in the manufacture of pharmaceuticals, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; inactive ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; plant-based ingredients for use in the manufacture of pharmaceuticals, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; inactive plant-based ingredients for use in the manufacture of pharmaceuticals, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; plant-based ingredients for use in the manufacture of pharmaceuticals, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; plant-based ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; inactive plant-based ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; plant-based ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; botanical ingredients for use in the manufacture of pharmaceuticals, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; inactive botanical ingredients for use in the manufacture of pharmaceuticals, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; botanical ingredients for use in the manufacture of pharmaceuticals, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; botanical ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; inactive botanical ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; botanical ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; herbal ingredients for use in the manufacture of pharmaceuticals, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; inactive herbal ingredients for use in the manufacture of pharmaceuticals, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; herbal ingredients for use in the manufacture of pharmaceuticals, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; herbal ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; inactive herbal ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; herbal ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; agricultural ingredients for use in the manufacture of pharmaceuticals, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; inactive agricultural ingredients for use in the manufacture of pharmaceuticals, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; agricultural ingredients for use in the manufacture of pharmaceuticals, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; agricultural ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; inactive agricultural ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; agricultural ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph | ACTIVE | — |
| 003 | Oils for cosmetic purposes, not for hair care products, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; cosmetics other than hair care products, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; skin and body topical lotions, creams and oils for cosmetic use, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; non-medicated skin care preparations, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; body oils, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; non-medicated body care products, namely, salves, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; lip balms, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; face creams, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; body lotions, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; body creams, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; hand lotions, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; hand creams, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; skin toners, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; night creams, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; eye creams, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; eye lotions, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; processed non-edible oils, not for hair care products, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act | ACTIVE | — |
| 004 | Hemp biomass not for use as fuel, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; CBD biomass not for use as fuel, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; non-edible organic material of the hemp plant that remains after the plant has been harvested and processed, namely, non-edible organic material of the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, that remains after the aforesaid plant has been harvested and processed, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act | ACTIVE | — |
| 005 | Non-edible oils for pharmaceutical purposes, including but not limited to massage oils, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; non-edible oils for nutraceutical purposes, including but not limited to massage oils, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; drinkable but non-edible oils for nutraceutical purposes, in the nature of dietary supplements, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing containing only naturally-occurring levels of CBD, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; medicinal oils, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; medicated shampoos, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; medicated soaps, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; medicated lotions for skin and body, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; plant extracts for pharmaceuticals for the purpose of promoting wellness, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; plant extracts for pharmaceutical purposes, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; plant extracts for the purpose of promoting wellness, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; plant extracts for the purpose of promoting wellness, in the nature of dietary supplements, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing containing only naturally-occurring levels of CBD, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act | ACTIVE | — |
| 029 | Processed edible oils, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing containing only naturally-occurring levels of CBD, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act | ACTIVE | — |
| 031 | Natural plants and flowers, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; seeds for sowing, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; seeds for planting, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; agricultural seeds, namely, hemp seeds, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; raw hemp, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; unprocessed hemp, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; raw hemp seeds, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; unprocessed hemp seeds, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act | ACTIVE | — |
| 034 | Rolling paper filled with smokable substances, containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; electronic cigarettes, containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; oral vaporizers for smokers, containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; cartridges sold filled with chemical flavorings in liquid form for electronic cigarettes, containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; herbs for smoking, containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; lighters for smokers, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act | ACTIVE | — |
| 035 | Online retail store services featuring a wide variety of consumer cosmetics goods of others, containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; online retail store services featuring a wide variety of non-medicinal consumer goods of others, containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; online retail store services featuring a wide variety of consumer goods of others, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; online retail store services featuring a wide variety of consumer goods of others, in the nature of dietary supplements, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing containing only naturally-occurring levels of CBD, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; online retail store services featuring non-medicinal smoking products, containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; online retail store services featuring apparel, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Stem Holdings IP, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 004
- Other trademarks in Class 005
- Other trademarks in Class 029
- Other trademarks in Class 031
- Other trademarks in Class 034
- Other trademarks in Class 035
- Similar marks named STEM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 11, 2026 | WOAG | WITHDRAWAL OF ATTORNEY GRANTED | — |
| Aug 11, 2026 | WOAR | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | — |
| Jul 28, 2026 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jul 23, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 23, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 23, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 22, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jan 15, 2026 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jul 14, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jul 12, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| May 24, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 24, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 24, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 11, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Nov 18, 2024 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Apr 3, 2024 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Feb 21, 2024 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Feb 20, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 18, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 16, 2024 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Aug 16, 2023 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Aug 15, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 12, 2023 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 7, 2022 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Mar 5, 2022 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Aug 30, 2021 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| May 27, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 27, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 27, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 23, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Dec 23, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Dec 23, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Dec 3, 2020 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Nov 25, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 5, 2020 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Nov 5, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 5, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 5, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 5, 2020 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| May 5, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 5, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 5, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 28, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 8, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 21, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 19, 2019 | NWAP | NEW APPLICATION ENTERED | — |